Table 2 Postoperative characteristics and resource utilization of the patient groups
Characteristics | Propofol (n = 44) | Dexmedetomidine (n = 44) | P value |
|---|---|---|---|
AF during 96Â h after surgery | 16 (36.4) | 6 (13.6) | 0.025 |
Onset of AF (h after operation) | 25.5 (19.5–36.4) | 40.4 (19.3–53.1) | 0.261 |
In-hospital mortality | 1 (2.3) | 0 (0) | >0.999 |
Mortality during study period | 1 (2.3) | 0 (0) | >0.999 |
Serum potassium before AF, mmol/L | 4.2 (3.9–4.3) | 4.0 (3.–4.1) | 0.083 |
Peak postoperative cTnI, ng/mL | 5.5 (2.9–9.5) | 6.9 (2.6–11.8) | 0.611 |
Hypotension | 13 (29.5) | 25 (56.8) | 0.017 |
Bradycardia | 1 (2.3) | 4 (9.1) | 0.360 |
Nausea/vomiting | 10 (22.7) | 9 (20.5) | >0.999 |
Delirium | 5 (11.4) | 0 (0) | 0.055 |
Acute kidney injury | 3 (6.8) | 5 (11.4) | 0.713 |
Mechanical ventilation ≥24 h | 6 (13.6) | 4 (9.1) | 0.739 |
Intubation time, h | 21.2 (17.0–22.8) | 21.0 (16.9–22.5) | 0.757 |
Length of ICU stay, days | 3.5 (2.7–4.5) | 2.9 (2.4–3.5) | 0.008 |
Length of hospital stay, days | 14.0 (11.0–17.0) | 13.5 (11.3–17.0) | 0.983 |
Postoperative hospital days | 8.0 (7.0–10.0) | 8.0 (7.0–9.8) | 0.505 |
Hospital fees, Chinese yuan, ×104 | 8.64 (7.32–9.63) | 7.79 (6.72–9.05) | 0.068 |